Arexera Therapeutics, Inc. has highlighted the emerging preclinical profile of ATL-101, the company’s wholly owned investigational HTT-lowering therapy for...
HTL Biotechnology has inaugurated its new production unit, HTL8, dedicated to the manufacture of pharmaceutical-grade polynucleotides, at its Javené...
DeepLife, a Paris-based techbio company developing AI-powered digital twins of human cells, and 3billion, an AI-powered genomics company specialising...
FibroBiologics, Inc. has announced that the European Patent Office has granted European Patent "Fibroblast Delivery of Tumor Inhibitory Agents."
The...
Unnatural Products, Inc. (UNP), a biotech developing orally-delivered macrocyclic peptides to address previously undruggable targets, has entered into a...